List of Excipients in API OMEGA-3-ACID ETHYL ESTERS
✉ Email this page to a colleague
Excipients in NDA-approved (novel) drugs containing OMEGA-3-ACID ETHYL ESTERS
| Company | Tradename | Ingredient | NDC | Excipient | Potential Generic Entry |
|---|---|---|---|---|---|
| GlaxoSmithKline LLC | LOVAZA | omega-3-acid ethyl esters | 0173-0783 | .ALPHA.-TOCOPHEROL | |
| GlaxoSmithKline LLC | LOVAZA | omega-3-acid ethyl esters | 0173-0783 | GELATIN | |
| GlaxoSmithKline LLC | LOVAZA | omega-3-acid ethyl esters | 0173-0783 | GLYCERIN | |
| GlaxoSmithKline LLC | LOVAZA | omega-3-acid ethyl esters | 0173-0783 | WATER | |
| Atlantic Biologicals Corps | LOVAZA | omega-3-acid ethyl esters | 17856-0084 | .ALPHA.-TOCOPHEROL | |
| Atlantic Biologicals Corps | LOVAZA | omega-3-acid ethyl esters | 17856-0084 | GELATIN | |
| >Company | >Tradename | >Ingredient | >NDC | >Excipient | >Potential Generic Entry |
Excipients in ANDA-approved (generic) drugs containing OMEGA-3-ACID ETHYL ESTERS
Detailed excipient profiles for OMEGA-3-ACID ETHYL ESTERS
Excipient focus: .ALPHA.-TOCOPHEROL
OMEGA-3-ACID ETHYL ESTERS drug variants containing .ALPHA.-TOCOPHEROL
OMEGA-3-ACID ETHYL ESTERS drug variants not containing .ALPHA.-TOCOPHEROL
Excipient focus: ALCOHOL
OMEGA-3-ACID ETHYL ESTERS drug variants containing ALCOHOL
OMEGA-3-ACID ETHYL ESTERS drug variants not containing ALCOHOL
Excipient focus: ALPHA-TOCOPHEROL
OMEGA-3-ACID ETHYL ESTERS drug variants containing ALPHA-TOCOPHEROL
OMEGA-3-ACID ETHYL ESTERS drug variants not containing ALPHA-TOCOPHEROL
Excipient focus: AMMONIA
OMEGA-3-ACID ETHYL ESTERS drug variants containing AMMONIA
OMEGA-3-ACID ETHYL ESTERS drug variants not containing AMMONIA
Excipient focus: BUTYL ALCOHOL
OMEGA-3-ACID ETHYL ESTERS drug variants containing BUTYL ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| Par Pharmaceutical Inc | omega-3-acid ethyl esters | 0254-3010 |
| AvPAK | omega-3-acid ethyl esters | 50268-676 |
| Strides Pharma Science Limited | omega-3-acid ethyl esters | 64380-761 |
| >Company | >Ingredient | >NDC |
OMEGA-3-ACID ETHYL ESTERS drug variants not containing BUTYL ALCOHOL
Excipient focus: DIMETHICONE
OMEGA-3-ACID ETHYL ESTERS drug variants containing DIMETHICONE
OMEGA-3-ACID ETHYL ESTERS drug variants not containing DIMETHICONE
Excipient focus: ETHYL ACETATE
OMEGA-3-ACID ETHYL ESTERS drug variants containing ETHYL ACETATE
| Company | Ingredient | NDC |
|---|---|---|
| Procaps S A | omega-3-acid ethyl esters | 49264-4274 |
| Chartwell RX LLC | omega-3-acid ethyl esters | 62135-780 |
| ANI Pharmaceuticals Inc | omega-3-acid ethyl esters | 62559-410 |
| >Company | >Ingredient | >NDC |
OMEGA-3-ACID ETHYL ESTERS drug variants not containing ETHYL ACETATE
Excipient focus: GELATIN
OMEGA-3-ACID ETHYL ESTERS drug variants containing GELATIN
OMEGA-3-ACID ETHYL ESTERS drug variants not containing GELATIN
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: GLYCERIN
OMEGA-3-ACID ETHYL ESTERS drug variants containing GLYCERIN
OMEGA-3-ACID ETHYL ESTERS drug variants not containing GLYCERIN
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: HYPROMELLOSE
OMEGA-3-ACID ETHYL ESTERS drug variants containing HYPROMELLOSE
OMEGA-3-ACID ETHYL ESTERS drug variants not containing HYPROMELLOSE
Excipient focus: HYPROMELLOSES
OMEGA-3-ACID ETHYL ESTERS drug variants containing HYPROMELLOSES
| Company | Ingredient | NDC |
|---|---|---|
| Camber Pharmaceuticals Inc | omega-3-acid ethyl esters | 31722-936 |
| XLCare Pharmaceuticals Inc | omega-3-acid ethyl esters | 72865-139 |
| >Company | >Ingredient | >NDC |
OMEGA-3-ACID ETHYL ESTERS drug variants not containing HYPROMELLOSES
Excipient focus: ISOPROPYL ALCOHOL
OMEGA-3-ACID ETHYL ESTERS drug variants containing ISOPROPYL ALCOHOL
OMEGA-3-ACID ETHYL ESTERS drug variants not containing ISOPROPYL ALCOHOL
Excipient focus: LECITHIN, SOYBEAN
OMEGA-3-ACID ETHYL ESTERS drug variants containing LECITHIN, SOYBEAN
| Company | Ingredient | NDC |
|---|---|---|
| Par Pharmaceutical Inc | omega-3-acid ethyl esters | 0254-3010 |
| AvPAK | omega-3-acid ethyl esters | 50268-676 |
| Strides Pharma Science Limited | omega-3-acid ethyl esters | 64380-761 |
| >Company | >Ingredient | >NDC |
OMEGA-3-ACID ETHYL ESTERS drug variants not containing LECITHIN, SOYBEAN
Excipient focus: MEDIUM-CHAIN TRIGLYCERIDES
OMEGA-3-ACID ETHYL ESTERS drug variants containing MEDIUM-CHAIN TRIGLYCERIDES
| Company | Ingredient | NDC |
|---|---|---|
| Chartwell RX LLC | omega-3-acid ethyl esters | 62135-780 |
| ANI Pharmaceuticals Inc | omega-3-acid ethyl esters | 62559-410 |
| >Company | >Ingredient | >NDC |
OMEGA-3-ACID ETHYL ESTERS drug variants not containing MEDIUM-CHAIN TRIGLYCERIDES
Excipient focus: POLYETHYLENE GLYCOL
OMEGA-3-ACID ETHYL ESTERS drug variants containing POLYETHYLENE GLYCOL
| Company | Ingredient | NDC |
|---|---|---|
| Procaps S A | omega-3-acid ethyl esters | 49264-4274 |
| >Company | >Ingredient | >NDC |
OMEGA-3-ACID ETHYL ESTERS drug variants not containing POLYETHYLENE GLYCOL
Excipient focus: POLYETHYLENE GLYCOL 400
OMEGA-3-ACID ETHYL ESTERS drug variants containing POLYETHYLENE GLYCOL 400
| Company | Ingredient | NDC |
|---|---|---|
| Chartwell RX LLC | omega-3-acid ethyl esters | 62135-780 |
| ANI Pharmaceuticals Inc | omega-3-acid ethyl esters | 62559-410 |
| >Company | >Ingredient | >NDC |
OMEGA-3-ACID ETHYL ESTERS drug variants not containing POLYETHYLENE GLYCOL 400
Excipient focus: POLYVINYL ACETATE PHTHALATE
OMEGA-3-ACID ETHYL ESTERS drug variants containing POLYVINYL ACETATE PHTHALATE
| Company | Ingredient | NDC |
|---|---|---|
| Procaps S A | omega-3-acid ethyl esters | 49264-4274 |
| Chartwell RX LLC | omega-3-acid ethyl esters | 62135-780 |
| ANI Pharmaceuticals Inc | omega-3-acid ethyl esters | 62559-410 |
| >Company | >Ingredient | >NDC |
OMEGA-3-ACID ETHYL ESTERS drug variants not containing POLYVINYL ACETATE PHTHALATE
Excipient focus: PROPYLENE GLYCOL
OMEGA-3-ACID ETHYL ESTERS drug variants containing PROPYLENE GLYCOL
OMEGA-3-ACID ETHYL ESTERS drug variants not containing PROPYLENE GLYCOL
Excipient focus: SHELLAC
OMEGA-3-ACID ETHYL ESTERS drug variants containing SHELLAC
OMEGA-3-ACID ETHYL ESTERS drug variants not containing SHELLAC
Excipient focus: SILICON DIOXIDE
OMEGA-3-ACID ETHYL ESTERS drug variants containing SILICON DIOXIDE
OMEGA-3-ACID ETHYL ESTERS drug variants not containing SILICON DIOXIDE
Excipient focus: SOYBEAN OIL
OMEGA-3-ACID ETHYL ESTERS drug variants containing SOYBEAN OIL
OMEGA-3-ACID ETHYL ESTERS drug variants not containing SOYBEAN OIL
Excipient focus: TITANIUM DIOXIDE
OMEGA-3-ACID ETHYL ESTERS drug variants containing TITANIUM DIOXIDE
OMEGA-3-ACID ETHYL ESTERS drug variants not containing TITANIUM DIOXIDE
Excipient focus: WATER
OMEGA-3-ACID ETHYL ESTERS drug variants containing WATER
OMEGA-3-ACID ETHYL ESTERS drug variants not containing WATER
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | omega-3-acid ethyl esters | 0093-5401 |
| QPharma Inc | omega-3-acid ethyl esters | 42708-067 |
| >Company | >Ingredient | >NDC |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
© Copyright 2002-2024 thinkBiotech LLC
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - HIPAA-ready chat for life sciences
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - HIPAA-ready chat for life sciences
Preferred Citation:
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2024, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch
Links
Follow DrugPatentWatch:
